Dr. Huang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Cedarssinai Comprehensive Transplant Center
8900 Beverly Boulevard 2ND floor
West Hollywood, CA 90048Phone+1 310-248-6528Fax+1 310-423-4678
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Nephrology, 2004 - 2006
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2001 - 2004
- University of Illinois College of MedicineClass of 2001
Certifications & Licensure
- CA State Medical License 2003 - 2026
- MD State Medical License 2007 - 2010
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Mechanisms of Belatacept Effect on Alloimmunity and Antiviral Response After Kidney Transplantation (BMS IM 103-309) Start of enrollment: 2013 Oct 01
- Longitudinal Changes in Donor-Derived Cell-Free DNA With Tocilizumab Treatment for Chronic Antibody-Mediated Rejection Start of enrollment: 2019 Mar 01
Publications & Presentations
PubMed
- 75 citationsKidney Transplantation in the ElderlyEdmund Huang, Dorry L. Segev, Hamid Rabb
Seminars in Nephrology. 2009-11-01 - 12 citationsPre-Transplant Weight Loss and Survival after Kidney Transplantation.Edmund Huang, Suphamai Bunnapradist
American Journal of Nephrology. 2015-07-25 - 28 citationsAssociation of pretransplant glycemic control with posttransplant outcomes in diabetic kidney transplant recipients.Miklos Z. Molnar, Edmund Huang, Junichi Hoshino, Mahesh Krishnan, Allen R. Nissenson
Diabetes Care. 2011-12-01
Press Mentions
- Regulatory Press Release: Hansa Biopharma Interim Report January–June 2019July 18th, 2019
- Plenary Presentation at the 2019 American Transplant Congress Demonstrates Significant Reduction in Time on the Waitlist for Patients Treated with Imlifidase Compared to Matched ControlsJune 7th, 2019
- Study Raises Questions About U.S. Kidney Allocation SystemApril 12th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: